Fesarius Therapeutics: Funding, Investors & Team (Oct 2026)
Fesarius Therapeutics is a biotechnology company that intends to develop and sell modified skin replacement products. To create a line of engineered tissue goods, developed a tissue engineering technique based on IP for microsphere-containing hydrogels. The company's method uses microspheres embedded in a collagen hydrogel to enhance the number of differential density interfaces that drive cell invasion into the scaffold, allowing patients to heal from trauma, burns, or infection at an affordable cost.
Fesarius Therapeutics has raised $20.0M across 1 funding round on record, the most recent a Series A of $20.0M announced in Jun 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Fesarius Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Fesarius Therapeutics Funding Rounds
Fesarius Therapeutics Founders and Leadership Team
Contact details for the Fesarius Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Fesarius Therapeutics Funding Compared to Other Biotechnology Startups
Fesarius Therapeutics' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Fesarius Therapeutics in Biotechnology and Brooklyn
Companies Similar to Fesarius Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Fesarius Therapeutics Funding FAQs
What does Fesarius Therapeutics do?
Fesarius Therapeutics is a biotechnology company that intends to develop and sell modified skin replacement products. To create a line of engineered tissue goods, developed a tissue engineering technique based on IP for microsphere-containing hydrogels. The company's method uses microspheres embedded in a collagen hydrogel to enhance the number of differential density interfaces that drive cell invasion into the scaffold, allowing patients to heal from trauma, burns, or infection at an affordable cost.
How much funding has Fesarius Therapeutics raised?
Fesarius Therapeutics has raised $20.0M across 1 round on record. The most recent is a Series A of $20.0M announced in Jun 2026.
When did Fesarius Therapeutics last raise funding?
Fesarius Therapeutics' most recent funding round on record is a Series A of $20.0M, announced in Jun 2026.
Who founded Fesarius Therapeutics?
FundedIQ lists Tom Roueche (Founder) at Fesarius Therapeutics.
Where is Fesarius Therapeutics headquartered?
Fesarius Therapeutics is based in Brooklyn, New York, United States.
How many employees does Fesarius Therapeutics have?
Fesarius Therapeutics is in the 1-10 employee band.
How does Fesarius Therapeutics' funding compare to other Biotechnology startups?
Fesarius Therapeutics' latest round of $20.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Fesarius Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Fesarius Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.